BACKGROUND: Posttransplantation diabetes mellitus (PTDM) is a major metabolic complication in renal transplant recipients. Recent genome-wide association studies have identified several genes associated with type 2 diabetes. Here, we examined the association between PTDM and 17 single nucleotide polymorphisms (SNPs) located within 15 genes in a cohort of renal allograft recipients in Korea. MATERIALS AND METHODS: A total of 589 patients who received kidney transplants between 1989 and 2007, without a history of diabetes and had a pretransplant fasting glucose less than 5.5 mmol/L were included in this study. We analyzed the association between the PTDM development and the following SNPs: TCF7L2 rs7903146, SLC30A8 rs13266634, HHEX (rs1111875, rs7923837, and rs5015480), CDKAL1 rs10946398, CDKN2A/B rs10811661, IGF2BP2 rs4402960, FTO rs8050136, WFS1 rs734312, JAZF1 rs864745, CDC123/CAMK1D rs12779790, TSPAN8 rs7961581, THADA rs7578597, ADAMTS9 rs4607103, NOTCH2 rs1092391, and KCNQ1 rs2237892. RESULTS: Eight SNPs in six genes were significantly associated with the PTDM development: TCF7L2 rs7903146 (odds ratio [OR]=2.20, P =0.016), SLC30A8 rs13266634 (OR=1.52, P =0.003), HHEX rs1111875 (OR=1.47, P =0.007), HHEX rs7923837 (OR=2.32, P =0.014), HHEX rs5015480 (OR=1.59, P =0.003), CDKAL1 rs10946398 (OR=1.43, P =0.008), CDKN2A/B rs10811661 (OR=1.33, P =0.039), and KCNQ1 rs2237892 (OR=1.46, P =0.009). CONCLUSIONS: These data suggest that genetic variations in TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, and KCNQ1 are associated with PTDM in Korea.
BACKGROUND:Posttransplantation diabetes mellitus (PTDM) is a major metabolic complication in renal transplant recipients. Recent genome-wide association studies have identified several genes associated with type 2 diabetes. Here, we examined the association between PTDM and 17 single nucleotide polymorphisms (SNPs) located within 15 genes in a cohort of renal allograft recipients in Korea. MATERIALS AND METHODS: A total of 589 patients who received kidney transplants between 1989 and 2007, without a history of diabetes and had a pretransplant fasting glucose less than 5.5 mmol/L were included in this study. We analyzed the association between the PTDM development and the following SNPs: TCF7L2rs7903146, SLC30A8rs13266634, HHEX (rs1111875, rs7923837, and rs5015480), CDKAL1rs10946398, CDKN2A/Brs10811661, IGF2BP2rs4402960, FTOrs8050136, WFS1rs734312, JAZF1rs864745, CDC123/CAMK1Drs12779790, TSPAN8rs7961581, THADArs7578597, ADAMTS9rs4607103, NOTCH2rs1092391, and KCNQ1rs2237892. RESULTS: Eight SNPs in six genes were significantly associated with the PTDM development: TCF7L2rs7903146 (odds ratio [OR]=2.20, P =0.016), SLC30A8rs13266634 (OR=1.52, P =0.003), HHEXrs1111875 (OR=1.47, P =0.007), HHEXrs7923837 (OR=2.32, P =0.014), HHEXrs5015480 (OR=1.59, P =0.003), CDKAL1rs10946398 (OR=1.43, P =0.008), CDKN2A/Brs10811661 (OR=1.33, P =0.039), and KCNQ1rs2237892 (OR=1.46, P =0.009). CONCLUSIONS: These data suggest that genetic variations in TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, and KCNQ1 are associated with PTDM in Korea.
Authors: Jaroslav A Hubacek; Ondrej Viklicky; Dana Dlouha; Silvie Bloudickova; Ruzena Kubinova; Anne Peasey; Hynek Pikhart; Vera Adamkova; Irena Brabcova; Eva Pokorna; Martin Bobak Journal: Nephrol Dial Transplant Date: 2011-07-25 Impact factor: 5.992
Authors: Dennis A Hesselink; Rachida Bouamar; Laure Elens; Ron H N van Schaik; Teun van Gelder Journal: Clin Pharmacokinet Date: 2014-02 Impact factor: 6.447
Authors: Lidia Ghisdal; Steven Van Laecke; Marc J Abramowicz; Raymond Vanholder; Daniel Abramowicz Journal: Diabetes Care Date: 2012-01 Impact factor: 19.112